abstract |
the present invention relates to methods of treating non-inflammatory lesions and their symptoms comprising administering to a subject who requires therapeutically efficient amount of amide of the acid (4s, 4, 5, 12) of -4-dimethylamino- 3,10,12,12a-tetrahydroxy-7 - [(methoxy (methyl) amino) -methyl] -1,11-dioxo-1,4,4a, 5,5a, 6,11,12a-octa- hydro-naphthacene-2-carboxylic or pharmaceutically acceptable salts thereof. in certain embodiments, a crystalline acid amide monohydrochloride, monomesylate or monosulfate salt (4s, 4, 5, 12)) -4- (dimethylamino) -3,10,12,12a-tetrahydroxy-7- [ (methoxy (methyl) amino) methyl] -1,11-dioxo-1,4,4a, 5,5a, 6,11,12a-octahydro-naphtacene-2-carboxylic. |